Keros Therapeutics (KROS) Stock Chart & Stock Price History → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free KROS Stock Alerts $56.03 +0.25 (+0.45%) (As of 03:09 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Keros Therapeutics Stock Price Performance5 Day Performance-4.95%1 Month Performance-14.94%3 Month Performance+0.57%6 Month Performance+96.60%Year-To-Date Performance+40.92%1 Year Performance+23.80% Receive KROS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… KROS Stock Chart for Tuesday, April, 23, 2024 KROS Chart by TradingView Keros Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$58.28$55.78-4.29%$59.60$55.54275,094 shs$2.01 billion04/19/2024$58.95$58.28-1.14%$59.90$56.15348,567 shs$2.10 billion04/18/2024$59.27$58.95-0.54%$61.33$58.15296,468 shs$2.12 billion04/17/2024$58.00$59.27+2.19%$59.50$56.53397,880 shs$2.13 billion04/16/2024$57.68$58.00+0.55%$58.94$56.59196,607 shs$2.09 billion04/15/2024$58.61$57.68-1.59%$59.87$57.26209,800 shs$2.08 billion Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024$61.90$58.61-5.32%$62.00$58.08331,782 shs$2.11 billion04/11/2024$60.83$61.90+1.76%$62.69$61.06221,786 shs$2.23 billion04/10/2024$63.81$60.83-4.67%$63.11$60.39272,976 shs$2.19 billion04/09/2024$63.19$63.81+0.98%$64.81$61.93212,855 shs$2.30 billion04/08/2024$62.66$63.19+0.85%$63.76$61.05218,028 shs$2.27 billion04/05/2024$61.71$62.66+1.54%$63.70$60.05166,938 shs$2.25 billion04/04/2024$63.98$61.71-3.55%$65.57$61.25223,787 shs$2.22 billion04/03/2024$64.02$63.98-0.06%$65.57$63.28196,991 shs$2.30 billion04/02/2024$66.89$64.02-4.29%$65.67$63.11294,234 shs$2.30 billion04/01/2024$66.20$66.89+1.04%$67.30$64.86215,950 shs$2.41 billion03/29/2024$66.20$66.20$67.01$63.59402,986 shs$2.38 billion03/28/2024$64.66$66.20+2.38%$67.01$63.59402,386 shs$2.38 billion03/27/2024$66.11$64.66-2.19%$65.86$59.14490,365 shs$2.33 billion03/26/2024$66.26$66.11-0.23%$67.49$65.22280,763 shs$2.38 billion03/25/2024$65.87$66.26+0.59%$67.42$65.52319,173 shs$2.38 billion03/22/2024$69.02$65.87-4.56%$69.26$65.36260,151 shs$2.37 billion03/21/2024$66.87$69.02+3.22%$69.89$66.85343,679 shs$2.48 billion03/20/2024$64.20$66.87+4.16%$67.00$63.24250,552 shs$2.41 billion03/19/2024$63.86$64.20+0.53%$65.06$62.79261,107 shs$2.31 billion03/18/2024$67.35$63.86-5.18%$67.12$63.62315,217 shs$2.30 billion03/15/2024$64.83$67.35+3.89%$68.30$64.241.68 million shs$2.42 billion03/14/2024$67.66$64.83-4.18%$67.25$63.64307,672 shs$2.33 billion03/13/2024$67.55$67.66+0.16%$69.63$66.80252,141 shs$2.43 billion03/12/2024$66.31$67.55+1.87%$69.69$65.88335,141 shs$2.43 billion03/11/2024$70.48$66.31-5.92%$70.58$65.75335,438 shs$2.39 billion03/08/2024$69.72$70.48+1.09%$71.27$69.14403,081 shs$2.54 billion03/07/2024$65.94$69.72+5.73%$70.16$66.41454,288 shs$2.51 billion03/06/2024$66.84$65.94-1.35%$68.00$64.95593,241 shs$2.37 billion03/05/2024$69.01$66.84-3.14%$69.36$64.42469,289 shs$2.40 billion03/04/2024$68.85$69.01+0.23%$70.00$67.48230,208 shs$2.48 billion03/01/2024$67.50$68.85+2.00%$71.00$67.73347,782 shs$2.06 billion02/29/2024$68.07$67.50-0.84%$73.00$66.56459,468 shs$2.02 billion02/28/2024$70.00$68.07-2.76%$70.69$67.63277,931 shs$2.04 billion02/27/2024$66.08$70.00+5.93%$70.67$66.84429,905 shs$2.10 billionThis Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry02/26/2024$63.61$66.08+3.88%$66.98$63.41401,970 shs$1.98 billion02/23/2024$60.99$63.61+4.30%$64.71$60.10582,710 shs$1.91 billion02/22/2024$59.72$60.99+2.13%$62.61$59.13231,058 shs$1.83 billion02/21/2024$60.77$59.72-1.73%$62.29$59.42285,717 shs$1.79 billion02/20/2024$59.49$60.77+2.15%$61.31$59.19384,892 shs$1.82 billion02/19/2024$59.49$59.49$61.09$56.22216,900 shs$1.78 billion02/16/2024$58.87$59.49+1.05%$61.09$56.22216,937 shs$1.78 billion02/15/2024$59.10$58.87-0.39%$60.94$58.27263,451 shs$1.76 billion02/14/2024$56.18$59.10+5.20%$59.28$55.47413,576 shs$1.77 billion02/13/2024$57.35$56.18-2.04%$57.17$54.21313,496 shs$1.68 billion02/12/2024$53.59$57.35+7.02%$57.41$53.50581,131 shs$1.72 billion02/09/2024$51.30$53.59+4.46%$54.31$51.63329,695 shs$1.61 billion02/08/2024$51.41$51.30-0.21%$57.24$50.10323,097 shs$1.54 billion02/07/2024$52.27$51.41-1.65%$53.00$50.90412,047 shs$1.54 billion02/06/2024$53.59$52.27-2.46%$54.49$51.57678,741 shs$1.57 billion02/05/2024$53.02$53.59+1.08%$53.88$52.02574,976 shs$1.61 billion02/02/2024$57.22$53.02-7.34%$57.06$52.15452,224 shs$1.59 billion02/01/2024$55.36$57.22+3.36%$58.00$55.37422,673 shs$1.71 billion01/31/2024$56.34$55.36-1.74%$57.98$55.22463,263 shs$1.66 billion01/30/2024$58.35$56.34-3.44%$58.04$54.95446,492 shs$1.69 billion01/29/2024$57.26$58.35+1.90%$58.50$56.40387,943 shs$1.75 billion01/26/2024$56.29$57.26+1.72%$58.10$55.84214,559 shs$1.72 billion01/25/2024$56.46$56.29-0.30%$58.62$55.10267,976 shs$1.69 billion01/24/2024$55.71$56.46+1.35%$58.22$55.53627,587 shs$1.69 billion01/23/2024$54.78$55.71+1.70%$56.39$53.54363,165 shs$1.67 billion01/22/2024$52.95$54.78+3.46%$55.00$52.13583,662 shs$1.64 billion Related Companies: Dyne Therapeutics Stock Price Chart Maravai LifeSciences Stock Price Chart TG Therapeutics Stock Price Chart Rocket Pharmaceuticals Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Geron Stock Price Chart Galapagos Stock Price Chart PTC Therapeutics Stock Price Chart Avidity Biosciences Stock Price Chart Arvinas Stock Price Chart Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KROS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.